YKL-40 is an inflammatory biomarker linked to tumour progression in various cancers, and its levels are consistently elevated in patients with T2D, a condition linked to increased risks for multiple ...

Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases. Given that the development ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Persistently elevated liver enzymes may be caused by certain types of cancer, including liver, colon, breast, stomach, pancreas, and skin cancers. Liver enzymes are proteins produced by your liver.

Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC ...